New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For GE;DELL;GSK;AZN;BEN;AAPL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>
November 19, 2014
09:41 EDTAAPLRubicon Project to partner with Apple on programmatic advertising
Subscribe for More Information
09:39 EDTAAPLActive equity options trading on open
Subscribe for More Information
08:04 EDTGEGE Healthcare announces Omnyx collaboration with Caradigm
GE Healthcare announced it will resell Caradigm’s Single Sign-On and Context Management solutions in the United States, Canada, and specific EU countries to provide connectivity between the Omnyx digital pathology platforms and designated Anatomic Pathology Laboratory Information Systems.
08:02 EDTAAPLApple's top competition is Google, says Jefferies
Jefferies calls Google (GOOG) Apple's (AAPL) top competition after its analysis indicated that the search engine giant provides the majority of most popular Consumer Cloud Services, which it believes are expanding penetration through Android, Chrome, iOS, Windows and other devices. By contrast, Apple's iCloud remains focused on iOS devices, Jefferies points out. It keeps a Hold rating on Apple shares, saying Google dominates as provider of the most popular services, including Search, Maps, Chrome, and YouTube. To reflect positive supply chain data points, Jefferies raised its FY15 earnings estimate for Apple to $8.52 to $8.01. It also upped its price target for Apple shares to $120 from $112. The stock closed yesterday up $1.48 to $115.47.
07:52 EDTGSK, AZNInforma Business Information to hold a conference
Subscribe for More Information
07:11 EDTAZNSanofi drawing up list of CEO candidates to repalce Viehbacher, Reuters reports
Sanofi's (SNY) board is in the process of drawing up a short list of CEO candidates to replace Chris Viehbacher, sources tell Reuters. Jean-Rene Fourtou, a Sanofi director and the honorary chairman of media group Vivendi (VIVHY), has been selected to lead the appointments and governance committee that will select the next CEO. Smith & Nephew (SNN) CEO Olivier Bohuon, AstraZeneca (AZN) CEO Pascal Soriot and former Wyeth CEO Bernard Poussot have been rumored to be potential contenders for the CEO position. Reference Link
06:42 EDTAAPLiPhone 7 could include 'biggest camera jump ever,' TheTechBlock reports
Subscribe for More Information
06:40 EDTAAPLSome iPhone 6 Plus users say rear camera doesn't focus, Business Insider reports
Subscribe for More Information
06:36 EDTAZNClovis rociletinib data 'good news/bad news,' says Mizuho
Mizuho analyst Peter Lawson says his initial read of the new rociletinib data is "good news/bad news," which leaves his price target for Clovis unchanged. Lawson pegs the bad news as the drug losing its progression-free survival lead since the estimated PFS dropped from 12 months to 10.4 months, essentially in-line with AstraZeneca's (AZN) competing drug AZD9291. Lawson sees the good news as the "encouraging" PFS of 7.5 months in T790M-negative patients. He keeps a Buy rating on Clovis with a $100 price target.
06:04 EDTAAPLApple to pay $23.6M to Mobile Telcommunictions in lawsuit, Re/code reports
Subscribe for More Information
November 18, 2014
16:00 EDTAAPLOptions Update; November 18, 2014
iPath S&P 500 VIX Short-Term Futures down 48c to 28.09. Option volume leaders: AAPL TSLA TWTR KO PBR GILD according to Track Data.
14:59 EDTAZNRanbaxy sues FDA for rescinding approval of Nexium, Valcyte copies, Reuters says
Subscribe for More Information
11:53 EDTAAPLSamsung to make foldable smartphone displays, ZDnet says
Subscribe for More Information
09:32 EDTAAPLActive equity options trading according to Track Data: AAPLTSLA TWTR FB
Subscribe for More Information
08:26 EDTAAPLApple Pay now available in all BI-LO, Harveys, Winn-Dixie grocery stores
Subscribe for More Information
08:01 EDTAAPLApple price target raised to $130 from $115 at Oppenheimer
Subscribe for More Information
07:29 EDTAZNPfizer less likely to pursue AstraZeneca after PD-L1 deal, says JPMorgan
Subscribe for More Information
07:20 EDTGSKEuro Organization for Research & Treatment of Cancer co-hosts a symposium
Subscribe for More Information
07:18 EDTAZNWoodford confident in Astra, sees 50% chance of new Pfizer bid, Reuters reports
Investment manager Neil Woodford of Woodford Investment Management said he now has an even stronger belief in AstraZeneca (AZN), citing the company's strong product pipeline, and put the chances of a new takeover bid from Pfizer (PFE) at 50/50, reported Reuters, citing a statement from Woodford. Reference Link
07:16 EDTAAPLSamsung to produce APs for iPhones, iPads beginning in 2015, Korea Times reports
According to the Korea Times, sources say that Apple (AAPL) will outsource the bulk of its application processors manufacturing to Samsung (SSNLF) for iPhones and iPads starting in 2015. This agreement will cause Samsung to become a primary supplier of APs to Apple, moving Taiwan Semi (TSM) into second place. Reference Link
<< 1 | 2 | 3 | 4 | 5 | 6 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use